Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue
Date:11/3/2010

ause their effect would be anti-dilutive.ONYX PHARMACEUTICALS, INC.

CALCULATION OF REVENUE FROM COLLABORATION AGREEMENT(In thousands, unaudited)Three Months EndedNine Months EndedSeptember 30, September 30, 2010200920102009Nexavar product revenue, net (as recorded by Bayer)$ 226,181$ 229,243$ 676,665$ 608,295Nexavar revenue subject to profit sharing (as recorded by Bayer)$ 191,553$ 199,774$ 580,399$ 548,093Combined cost of goods sold, distribution, selling, general and administrative expenses78,46476,309237,184222,531Combined collaboration commercial profit$ 113,089$ 123,465$ 343,215$ 325,562Onyx's share of collaboration commercial profit$   56,545$   61,732$ 171,607$ 162,781Reimbursement of Onyx's shared marketing expenses4,7275,34217,02616,079Royalty revenue2,4242,0636,7394,214Revenue from collaboration agreement$   63,696$   69,137$ 195,372$ 183,074ONYX PHARMACEUTICALS, INC.

RECONCILIATION OF GAAP TO NON-GAAP NET INCOME (LOSS)(In thousands, except per share amounts)

(unaudited)Three Months EndedNine Months EndedSeptember 30, September 30, 2010200920102009GAAP net income (loss)

$
41,500$
8,233$   (67,726)$
21,672Non-GAAP adjustments:Contingent consideration

5,622-101,107-Employee stock-based compensation

5,8744,97216,59214,933Imputed interest related to the convertible senior notes due 2016

2,2921,0276,6711,027Acquisition related transaction costs

-1,011-1,011Milestone payments

-7,000-7,000Non-GAAP net income (3)$
55,288$
22,243$
56,644$
45,643Computation of non-GAAP diluted net income (loss)Non-GAAP net income (3)$
55,288$
22,243$
56,644$
45,643Add:Interest and issuance costs related to dilutive convertible senior notes (4)2,5321,228-1,228Non-GAAP net income - diluted (3)$
57,820$
23,471$
56,644$
46,871Computation of non-GAAP diluted sharesBasic shares

62,70760,24862,56258,201Dilutive effect of optio
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Vanda Pharmaceuticals Reports Third Quarter 2010 Results
2. OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million
3. Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010
4. Anthera Pharmaceuticals Reports 2010 Third Quarter Financial Results and Operational Update
5. ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
6. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
7. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
8. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
9. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
10. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
11. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... MONMOUTH JUNCTION, N.J. , Dec. 22, 2014 ... immunotherapy company marketing its CytoSorb® blood purification technology ... cardiac surgery patients in 28 countries worldwide, today ... Di Russo , MD, FACS, as its Senior ... 2015. Dr. Di Russo ...
(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ... Self-monitoring Blood Glucose Market" report to their offering. ... This market insight focuses on the developments in the ... States . Reimbursement analysis and the effects of ... more than 73 SMBG meters have been performed, based ...
(Date:12/22/2014)... , Dec. 22, 2014  ConvaTec, a privately-held medical ... has been appointed Interim Chief Executive Officer of the ... succeeds Ken Berger .  "The Board of Directors ... leading ConvaTec over the past three years," said ... Directors.  "We are confident that the company is well ...
Breaking Medicine Technology:CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... received 510(k) clearance from the U.S. Food and Drug ... spot scanning. Spot scanning is a proton therapy delivery ... the tumor by using thousands of small individual beamlets ... Intensity Modulated Proton Therapy (IMPT). XiO, Elekta,s ...
... 3, 2010 Halozyme Therapeutics, Inc. (Nasdaq: ... commercializing products targeting the extracellular matrix , today ... serve as president and CEO, effective immediately. Jonathan E. ... of the board of directors to pursue other opportunities. ...
Cached Medicine Technology:Elekta Receives FDA 510(k) Clearance for XiO Software to Plan Spot Scanning for Proton Therapy 2Halozyme Therapeutics Realigns Management 2Halozyme Therapeutics Realigns Management 3
(Date:12/24/2014)... Dec. 24, 2014 (HealthDay News) -- A lab technician ... may have been exposed to the Ebola virus in ... And up to a dozen other lab workers are ... Wednesday afternoon. The possible exposure occurred Monday when ... sample of the potentially lethal virus to another CDC ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Gluten, a ... on those who have an intolerance to gluten, causing ... gas, bloating, migraine headaches, joint pain and fatigue. For ... diet plans that deliver safe and fast weight ... that trigger a gluten allergy reaction. These gluten free ...
(Date:12/24/2014)... Jacksonville, Florida (PRWEB) December 24, 2014 The ... a safer place to raise families. In-Vest USA ... those who protect us – our first responders. Today, these ... law enforcement officers by providing them with body armor through ... like the tragic shootings that happened this past week in ...
(Date:12/24/2014)... Dallas, Texas (PRWEB) December 24, 2014 ... COC Industry is a professional and in-depth research ... the report introduces COC basic information, including its ... policy analysis, news analysis, etc. This report also ... structure etc. Production is separated by regions, technology ...
(Date:12/24/2014)... FL (PRWEB) December 24, 2014 There’s a ... days. With the Republican Party now in control of the ... again for the Affordable Care Act. A lawsuit has been ... delays of certain provisions in the ACA have resulted in ... Also, a Supreme Court hearing will take place to weigh ...
Breaking Medicine News(10 mins):Health News:CDC Monitors Lab Worker for Possible Ebola Exposure 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 2Health News:Diet Doc Adds Gluten Free Diet Plans to Their Stable of Specialized Weight Loss Programs 3Health News:The Healthy Home Company and In-Vest USA Team Up to Save the Lives of Law Enforcement 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 3
... Travel Advantage Network , one of the nation,s ... Susan G. Komen for the Cure , the global leader ... pin sales and a Jeans Day, where employees purchase the ... employees raised $729 for Susan G. Komen for the Cure, ...
... 22 McAuley Ministries, the new grant-making arm of ... first grant... and the recipient is the YMCA of ... the construction of a green rooftop terrace for the ... new Thelma Lovette YMCA touches several of McAuley Ministries ...
... Aurora Health Care announced today that,the physicians ... join Aurora Medical Group. , ... Paul,Guzzetta, M.D., and Mark Plumb, M.D. All are board-certified ... specializes and is,board-certified in the treatment of sleep disorders. ...
... In the year following Hurricane Katrina, the health of ... of a national sample of older adults not affected ... researchers at the Johns Hopkins Bloomberg School of Public ... most powerful and deadliest hurricanes in U.S. history. Hurricane ...
... the founder and longtime director of the HIV advocacy/education ... Institute of Allergy and Infectious Diseases (NIAID) Director,s Special ... against HIV/AIDS. , Mr. Delaney in 1985 ... public policy information and advocacy organization based in San ...
... , Montreal, January 22, 2009 The ... that preventive treatment with high doses of inhaled corticosteroids ... asthma attacks triggered by colds. Dr. Francine Ducharme, assistant ... Center and a pediatrics professor at the Universit de ...
Cached Medicine News:Health News:Grassroots Group Gets Travel Advantage Network Support 2Health News:YMCA of Greater Pittsburgh Receives $500,000 from McAuley Ministries for New Hill YMCA Roof 2Health News:YMCA of Greater Pittsburgh Receives $500,000 from McAuley Ministries for New Hill YMCA Roof 3Health News:Midwest Pulmonary and Critical Care Associates Will Join Aurora Medical Group 2Health News:Decline in health among older adults affected by Hurricane Katrina 2Health News:NIAID honors AIDS activist Martin Delaney 2Health News:New treatment reduces severity of asthma attacks in preschoolers 2